Replimune Group Inc • REPL

Capital at risk.

About Replimune Group Inc
Ticker
info
REPL
Trading on
info
NASDAQ
ISIN
info
US76029N1063
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Sushil Patel Ph.D.
Headquarters
info
500 Unicorn Park Drive, Woburn, MA, United States, 01801
Employees
info
479
Website
info
replimune.com
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company's proprietary oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors. The company is also developing RP2 that express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3, which express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$810M
P/E ratio
info
-
EPS
info
-$3.47
Dividend Yield
info
0.00%
Beta
info
0.67
Forward P/E ratio
info
0
EBIDTA
info
$-313M
Ex dividend date
info
-
Price & volume
Market cap
info
$810M
Average daily volume
info
2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
3.07
Earnings
EPS
info
-$3.47
EPS estimate (current quarter)
info
-$0.79
EPS estimate (next quarter)
info
-$0.70
EBITDA
info
$-313M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
0.67
52-week High
info
$14.80
52-week Low
info
$2.68
50-day moving average
info
$7.38
200-day moving average
info
$8.27
Short ratio
info
2.15
Short %
info
39.81%
Management effectiveness
ROE (TTM)
info
-96.24%
ROA (TTM)
info
-44.83%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
78.4M
Float
info
52.8M
Insiders %
info
1.98%
Institutions %
info
106.78%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 8 analysts.

Average price target

info
$12.57
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.79
-$0.72
-9.72%
Q4 • 24Missed
-$0.82
-$0.69
-18.84%
Q1 • 25Missed
-$0.95
-$0.80
-18.75%
Q2 • 25Missed
-$0.90
-$0.84
-7.14%
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-86.7M
-∞%
Q2 • 25
$0M
$-83.1M
-∞%
Q3 • 25
NaN%
-4.14%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$470M
$133M
28.28%
Q2 • 25
$389M
$126M
32.38%
Q3 • 25
-17.05%
-5.03%
14.49%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-77M
$65M
$-0.2M
$-79.8M
Q2 • 25
$-81.2M
$84.2M
$0.3M
$-82.6M
Q3 • 25
5.45%
29.40%
-305.06%
3.51%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Replimune Group Inc share?
Collapse

Replimune Group Inc shares are currently traded for undefined per share.

How many shares does Replimune Group Inc have?
Collapse

Replimune Group Inc currently has 78.4M shares.

Does Replimune Group Inc pay dividends?
Collapse

No, Replimune Group Inc doesn't pay dividends.

What is Replimune Group Inc 52 week high?
Collapse

Replimune Group Inc 52 week high is $14.80.

What is Replimune Group Inc 52 week low?
Collapse

Replimune Group Inc 52 week low is $2.68.

What is the 200-day moving average of Replimune Group Inc?
Collapse

Replimune Group Inc 200-day moving average is $8.27.

Who is Replimune Group Inc CEO?
Collapse

The CEO of Replimune Group Inc is Dr. Sushil Patel Ph.D..

How many employees Replimune Group Inc has?
Collapse

Replimune Group Inc has 479 employees.

What is the market cap of Replimune Group Inc?
Collapse

The market cap of Replimune Group Inc is $810M.

What is the P/E of Replimune Group Inc?
Collapse

The current P/E of Replimune Group Inc is null.

What is the EPS of Replimune Group Inc?
Collapse

The EPS of Replimune Group Inc is -$3.47.

What is the PEG Ratio of Replimune Group Inc?
Collapse

The PEG Ratio of Replimune Group Inc is null.

What do analysts say about Replimune Group Inc?
Collapse

According to the analysts Replimune Group Inc is considered a buy.